Marathon Pharmaceuticals LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://marathonpharma.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001
Phase 3
Withdrawn
- Conditions
- Short Gut SyndromeShort Bowel SyndromeSBSShort Gut
- Interventions
- Drug: 0.6 mL, MP-101 (10 mg/mL, Opium Tincture (OT)), USP (Deodorized)
- First Posted Date
- 2014-09-23
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- Marathon Pharmaceuticals, LLC
- Registration Number
- NCT02246816
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸Indiana University, Indianapolis, Indiana, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals
Phase 3
Withdrawn
- Conditions
- SBSShort Gut SyndromeShort Bowel SyndromeShort BowelShort Gut
- Interventions
- First Posted Date
- 2014-09-17
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- Marathon Pharmaceuticals, LLC
- Registration Number
- NCT02242656
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸Indiana University, Indianapolis, Indiana, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
News
No news found